Changes of heart rate and power spectrum of its fluctuations induced by a short-term course of quinidine in patients with various arrhythmias

Kardiologiya

Volumn 38, Issue 1, 1998, Pages 22-30

  Khayutin, V M ^a   Bekbosynova, M S ^a   Lukoshkova, E V ^a   Golitsin, S P ^a  

^a NONE

Author keywords

Arrhythmias; Heart rate; Low and high frequency fluctuations; Quinidine; Spectrum analysis

Indexed keywords

EID: 3342967736     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Vaughan Williams E.M. Relevance of celllular to clinical electrophysiology in interpreting antiarrhythmic drug action. Am J Cardiol 1989;64:Suppl J:J5-J9.
2. Mirro M.J., Manalan A.S., Bailey J.C., Watanabe A.M. Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Circulat Res 1980;47:855-865.
3. Hyatt E., Brown D., Qinn G., Macduffie K. The blocking action of cinchona alkaloides and certain related compounds on the cardio-inhibitory vagus endings of the dog. J Pharmacol Exp Ther 1945;85:55-60.
4. James T.N., Nadeau R.A. The mechanism of action of quinidine in the sinus node studied by direct perfusion through its artery. Am Heart J 1964;67:804-811.
5. Josephson M.E., Seides S.F., Batsford W.P. et al. The electrophysiological effects of intramuscular quinidine on the atrioventricular conducting system in man. Am Heart J 1974;87:55-64.
6. Ferrer I.M., Harvey M., Werbo L. et al. Some effects of quinidine sulfate on the heart and circulation in man. Am Heart J 1948;36:816 -837.
7. Schmidt P.G., Nelson L.D., Mark A.L. et al. Inhibition of adrenergic vasoconstriction by quinidine. J Pharmacol Exp Ther 1974;188:124-134.
8. 2-adrenoreceptor blocking properties of dihydroquinidine and dihydroqinine. Drug Res 1983;33:694-698.
9. 2-adrenoreceptors. Circulat Res 1984;55:376-381.
10. Robertis J., Stradter R.P., Cairoli V., Modell W. Relationship between adrenergic activity and cardiac action of quinidine. Circulat Res 1962;11:758-764.
11. Carliner N.H., Fisher M.L., Crouthamel W.G. et al. Relation of ventricular premature beat suppression to serum quinidine concentration determined by a new and specific assay. Am Heart J 1980;100:483-489.
12. Wallas A.G., Ceine R.E., Sealy W.C. Electrophysiological effects of quinidine. Studies using chronically implanted electrodes in awake dogs with and without cardiac denervation. Circulat Res 1966;19:960 -969.
13. Cambell T.J. Clinical use of class Ia antiarrhythmic drugs. Ch.9. In: Antiarrhythmic drugs. Ed. E.M. Vaughan Williams. Berlin: Springer Verlag 1989;175-199.
14. Mason J.W., Winkle R.A., Rider A.K. et al. The electrophysiological effects of quinidine in the transplanted human heart. J Clin Invest 1977;59:481-489.
15. Bailey J.R., Crossley G.H., Simmons T.W. et al. Disparate effects of procainamide and quinidine on heart rate variability. Circulation 1995;92:Suppl I:I-730-I-731.
16. Ewing D.J., Neilson J.M.M., Shapiro C.M. et al. Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J 1991;65:239-244.
17. Cerutti S., Bianchi A.M., Mainardi L.T. Spectral analysis of the heart rate variability signal. Ch.5. In: Heart rate variability. Eds. M. Malik, A.J. Camm. New York: Futura Publ Co Armonk 1995;63 -74.
18. Gill J.S., Zezulka A.V., Beeveres D.G., Davies P. Relation between initial blood pressure and its fall with treatment. Lancet 1985;1:567 -569.
19. Odemuyiwa O. Effect of age on heart rate variability. Ch.18. In: Heart rate variability. Eds. M. Malik, A.J. Camm. New York: Futura Publ Co Armonk 1995;235-240.
20. Hirsh J.A., Bishop B. Respiratory sinus arrhythmia in humans: how breathing pattern modulates heart rate. Am J Physiol 1981;241:H620 -H629.
21. Laude D., Goldman M., Escourrou P., Elghozi J.-L. Effect of breathing pattern on blood pressure and heart rate oscillations in humans. Clin Exp Pharmacol Physiol 1993;20:619-626.
22. Pomeranz B.R.J., Macaulay B., Caudill M.A. et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153.
23. Wellens H.G., Durer D. Effect of procainamid, quinidine and ajmaline in the Wolff-Parkinson-White syndrome. Circulation 1974;50:114-120.
24. Hirshfield D.S., Ueda T., Rowland M., Scheinman M.M. Clinical and electrophysiological effects of intravenous quinidine in man. Br Heart J 1977;39:309-316.
25. Conrad K.A., Molk B.L., Chidsey C.A. Pharmacokinetics studies of quinidine in patients with arrhythmias. Circulation 1977;55:1-8.
26. Swerdlow C.D., Yu J.O., Jacobson E. et al. Safety and efficacy of intravenous quinidine. Am J Med 1983;75:36-42.
27. Alboni P., Papparella N., Pirani R. et al. Different electrophysiological modes of action of oral quinidine in man. Eur Heart J 1985;6:946-953.
28. Alboni P., Cappato R., Papparella N. et al. Electrophysiological effects and mechanism of action of oral quinidine in patients with sinus bradicardia and first degree A - V nodal block. Eur Heart J 1987;8:1080-1089.
29. Greenblatt D.J., Pffeifer H.J., Ochs H.R. et al. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration. J Pharmac Exp Ther 1977;202:365-378.
30. Ochs H.R., Grube E., Greenblatt D.J. Intravenous quinidine: Pharmacokinetic properties and effects on left ventricular performance in humans. Am Heart J 1980;99:468-475.
31. Crawford M.H., White D.H., O'Rourke R.A. Effects of oral quinidine on left ventricular performance in normal subjects and patients with congestive cardiomyopathy. Am J Cardiol 1979;44:714 -718.